These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 16176441)
1. Zotepine loading in acute and severely manic patients: a pilot study. Amann B; Sterr A; Mergl R; Dittmann S; Seemüller F; Dobmeier M; Orth M; Schaefer M; Grunze H Bipolar Disord; 2005 Oct; 7(5):471-6. PubMed ID: 16176441 [TBL] [Abstract][Full Text] [Related]
2. A single-blind, comparative study of zotepine versus haloperidol in combination with a mood stabilizer for patients with moderate-to-severe mania. Chan HY; Jou SH; Juang YY; Chang CJ; Chen JJ; Chen CH; Chiu NY Psychiatry Clin Neurosci; 2010 Apr; 64(2):162-9. PubMed ID: 20447012 [TBL] [Abstract][Full Text] [Related]
3. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms. McIntyre RS; Konarski JZ; Jones M; Paulsson B J Affect Disord; 2007; 100 Suppl 1():S5-14. PubMed ID: 17391773 [TBL] [Abstract][Full Text] [Related]
4. Quetiapine in the treatment of acute mania: target dose for efficacious treatment. Vieta E; Goldberg JF; Mullen J; Vågerö M; Paulsson B J Affect Disord; 2007; 100 Suppl 1():S23-31. PubMed ID: 17382403 [TBL] [Abstract][Full Text] [Related]
5. Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study. Haas M; Delbello MP; Pandina G; Kushner S; Van Hove I; Augustyns I; Quiroz J; Kusumakar V Bipolar Disord; 2009 Nov; 11(7):687-700. PubMed ID: 19839994 [TBL] [Abstract][Full Text] [Related]
6. Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study. Vieta E; Calabrese JR; Goikolea JM; Raines S; Macfadden W; Bipolar Disord; 2007 Jun; 9(4):413-25. PubMed ID: 17547587 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study). Thase ME; Macfadden W; Weisler RH; Chang W; Paulsson B; Khan A; Calabrese JR; J Clin Psychopharmacol; 2006 Dec; 26(6):600-9. PubMed ID: 17110817 [TBL] [Abstract][Full Text] [Related]
8. Ziprasidone monotherapy in bipolar II depression: an open trial. Liebowitz MR; Salmán E; Mech A; Dunner D; Johnson AE; Akhtar J; Pratap R J Affect Disord; 2009 Nov; 118(1-3):205-8. PubMed ID: 19264363 [TBL] [Abstract][Full Text] [Related]
9. Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM). Vieta E; Angst J; Reed C; Bertsch J; Haro JM; J Affect Disord; 2009 Nov; 118(1-3):118-23. PubMed ID: 19269690 [TBL] [Abstract][Full Text] [Related]
10. Tolerability of oral loading of divalproex sodium in the treatment of acute mania. Martinez JM; Russell JM; Hirschfeld RM Depress Anxiety; 1998; 7(2):83-6. PubMed ID: 9614597 [TBL] [Abstract][Full Text] [Related]
11. Memantine efficacy and safety in patients with acute mania associated with bipolar I disorder: a pilot evaluation. Keck PE; Hsu HA; Papadakis K; Russo J Clin Neuropharmacol; 2009; 32(4):199-204. PubMed ID: 19620854 [TBL] [Abstract][Full Text] [Related]
12. Allopurinol as an adjunct to lithium and haloperidol for treatment of patients with acute mania: a double-blind, randomized, placebo-controlled trial. Akhondzadeh S; Milajerdi MR; Amini H; Tehrani-Doost M Bipolar Disord; 2006 Oct; 8(5 Pt 1):485-9. PubMed ID: 17042886 [TBL] [Abstract][Full Text] [Related]
13. The factor structure of clinical symptoms in mixed and manic episodes prior to and after antipsychotic treatment. Harvey PD; Endicott JM; Loebel AD Bipolar Disord; 2008 Dec; 10(8):900-6. PubMed ID: 19594505 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of quetiapine monotherapy in rapid-cycling bipolar disorder in comparison with sodium valproate. Langosch JM; Drieling T; Biedermann NC; Born C; Sasse J; Bauer H; Walden J; Bauer M; Grunze H J Clin Psychopharmacol; 2008 Oct; 28(5):555-60. PubMed ID: 18794653 [TBL] [Abstract][Full Text] [Related]
15. A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder. DelBello MP; Chang K; Welge JA; Adler CM; Rana M; Howe M; Bryan H; Vogel D; Sampang S; Delgado SV; Sorter M; Strakowski SM Bipolar Disord; 2009 Aug; 11(5):483-93. PubMed ID: 19624387 [TBL] [Abstract][Full Text] [Related]
16. Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study. Amsterdam JD; Shults J J Clin Psychopharmacol; 2008 Apr; 28(2):171-81. PubMed ID: 18344727 [TBL] [Abstract][Full Text] [Related]
17. Inositol augmentation of lithium or valproate for bipolar depression. Eden Evins A; Demopulos C; Yovel I; Culhane M; Ogutha J; Grandin LD; Nierenberg AA; Sachs GS Bipolar Disord; 2006 Apr; 8(2):168-74. PubMed ID: 16542187 [TBL] [Abstract][Full Text] [Related]
18. Risperidone monotherapy in manic inpatients: an open label, multicentre trial. Forsthoff A; Grunze H; Seemüller F; Stampfer R; Dittmann S; Amann B; Schmidt F; Schäfer M; Hermle L; Walden J; Schreiner A World J Biol Psychiatry; 2007; 8(4):256-61. PubMed ID: 17853251 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness of quetiapine in rapid cycling bipolar disorder: a preliminary study. Goldberg JF; Kelley ME; Rosenquist KJ; Hsu DJ; Filkowski MM; Nassir Ghaemi S J Affect Disord; 2008 Jan; 105(1-3):305-10. PubMed ID: 17550787 [TBL] [Abstract][Full Text] [Related]
20. Validation of a severity threshold for the Mania Rating Scale: a receiver-operating characteristic analysis. Azorin JM; Kaladjian A; Akiskal HS; Hantouche EG; Duchêne LC; Gury C; Lancrenon S Psychopathology; 2007; 40(6):453-60. PubMed ID: 17709976 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]